explore -WSS

explore

author：Wikipedia 2025-09-29 07:50:01 - browse：22934

Obesity conference attendees with a pink and blue Wegovy sign hanging from the ceiling above. -- obesity coverage from STAT — Wegovy, the obesity drug, was inescapable at the ObesityWeek conference in Dallas. Elaine Chen

DALLAS — Here at ObesityWeek, one of the largest conferences on obesity, Novo Nordisk and Eli Lilly are displaying more than a dozen studies that together carry the message: Our blockbuster weight loss treatments will be worth it for society.

But experts point out that much of this company-funded research does not include the cost of the drugs themselves, which sell at more than $10,000 per year in the U.S. and are meant to be taken indefinitely.

The two major pharmaceutical companies have seen interest skyrocket for their GLP-1-based drugs like Ozempic, Wegovy, and Mounjaro, a new generation of medications that can cut substantial amounts of weight. But insurance plans have been slow to grant wide access to obesity treatments, concerned that the vast amount of people eligible to take them, along with their high price, could lead to significant financial strain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Churchill Downs extends trainer Bob Baffert's ban through 2024

focus

explore

WSS

Trump pressured former Arizona governor to overturn 2020 election results: Sources

Churchill Downs extends trainer Bob Baffert's ban through 2024

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

Noem? Reynolds? A very early look at the Republican 'veepstakes'

At least 13 dead in Texas as scorching temps continue

Apple is now the first public company to be valued at $3 trillion

focus

explore

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Noem? Reynolds? A very early look at the Republican 'veepstakes'

Medicare proposal to cover medical devices draws a mixed reaction

July 4th fireworks can be stressful for dogs. These 6 tips can keep them calm and safe

Heart attack and stroke risk calculators need revising

Guidelines to prevent youth baseball injuries need more muscle

DIEP, the 'gold standard' of breast reconstruction, is under threat

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

Cancer drug shortages should be causing more outrage

New air purifier tech could be key to improving indoor air quality

hotspot

ThunderShirts, dance parties and anxiety meds can help ease dogs' July Fourth dread

10 states plan to sue EPA over standards for residential wood

10 states plan to sue EPA over standards for residential wood

United colonoscopy coverage change 'may cost lives,' doctors say

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

Cancer drug shortages should be causing more outrage

focus

explore

explore

focus